Alex H Gifford

6PUBLICATIONS
12CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPacific Peoples cultural determinants of healthCarbon capture engineering (excl. sequestration)Medical infection agents (incl. prions)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 22, 2025
Improving Modulator Management and Side Effect Screening: A CF Learning Network Innovation Lab.

Kevin P Lonabaugh, Anna Saulitis, Elizabeth Boettinger

|Apr 16, 2021
Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.

Alex H Gifford, Julie L Sanville, Meghana Sathe

|Jan 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design.

Nicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis

|Nov 02, 2019
Does Ivacaftor Taken Twice a Day Keep the Pseudomonas Away?

Alex H Gifford, Sonya L Heltshe

|Mar 30, 2019
Perspectives on anemia and iron deficiency from the cystic fibrosis care community.

Gretchen M Garlow, Lucy S Gettle, Nicola J Felicetti

|Dec 25, 2018
CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis.

Alex H Gifford, Sonya L Heltshe, Christopher H Goss

Pageof 1